PDS Biotechnology Corp (PDSB) Form 424B4 — Jul 21, 2026
PDS Biotechnology Corporation filed a prospectus supplement allowing the resale of up to 13,315,823 shares of common stock by YA II PN, LTD. The shares consist of 2,158,274 shares issuable upon exercise of a warrant and up to 11,157,549 shares issuable upon conversion of a promissory note related to a private placement that closed on June 15, 2026. The company will not receive any proceeds from the resale of these shares by the selling stockholder. The underlying transaction involved a $6 million promissory note with a 10% interest rate and a warrant with an exercise price of $1.1824 per share, which is currently above the market price of $0.7173 per share.
Key figures
- Debt Amount
- $6,000,000
- Interest Rate
- 10%
- Shares Offered
- 13,315,823
- Shares Outstanding
- 55,921,806
- Warrant Shares
- 2,158,274
- Note Conversion Shares
- 11,157,549
- Warrant Exercise Price
- $1.1824
- Original Issue Discount
- 4%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.